June 26, 2014 BY EMAIL Ken Bartizal, Ph.D. Bend, OR 97701 Re: Employment Agreement Dear Dr. Bartizal:Employment Agreement • March 13th, 2015 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 13th, 2015 Company Industry JurisdictionOn behalf of K2 Therapeutics, Inc. (the “Company”), I am pleased to offer you the position of the Company’s Chief Development Officer (“CDO”). The terms of your employment are set forth below.
July 15, 2014 BY EMAIL Dirk Thye, M.D. PO Box 330365, San Francisco, CA 94133 Re: Employment Agreement Dear Dr. Thye:Employment Agreement • March 13th, 2015 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 13th, 2015 Company Industry JurisdictionOn behalf of Cidara Therapeutics, Inc. (the “Company”), I am pleased to offer you the position of the Company’s Chief Medical Officer (“CMO”). The terms of your employment are set forth below.
July 18, 2014 BY EMAIL Kevin Forrest, Ph.D. Newton, MA 02459 Re: Amended and Restated Employment Agreement Dear Dr. Forrest:Employment Agreement • March 13th, 2015 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 13th, 2015 Company Industry JurisdictionThis letter agreement (the “Agreement”) sets forth the terms of your continued employment as Chief Operating Officer (“COO”) of Cidara Therapeutics, Inc. (the “Company”). This Agreement will become effective upon your acceptance by executing this Agreement and returning the executed Agreement to me. As of its effective date this Agreement replaces and supersedes in its entirety the letter agreement between you and K2 Therapeutics, Inc. dated June 25, 2014 (the “Prior Agreement”) except that the terms of your Employee Confidentiality Assignment and Nonsolicitation Agreement executed on May 30, 2014 (the “Restrictive Covenant Agreement”) shall continue to apply.
Re: Employment AgreementEmployment Agreement • February 4th, 2015 • K2 Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledFebruary 4th, 2015 Company Industry JurisdictionThis letter agreement (the “Agreement”) sets forth the terms of your employment as the Chief Commercial Officer (“CCO”) of CIDARA Therapeutics, Inc. (the “Company”). This Agreement will become effective upon your acceptance by executing this Agreement and returning the executed Agreement to me.